144
Views
0
CrossRef citations to date
0
Altmetric
Original Research

Factors associated with anxiety and depression among patients with chronic obstructive pulmonary disease

, ORCID Icon, , , & ORCID Icon
Pages 59-65 | Received 15 Nov 2023, Accepted 29 Feb 2024, Published online: 07 Mar 2024

References

  • World Health Organization. The top 10 causes of death [Internet]. 2020 [cited 2022 May 9]. Available from: https://www.who.int/en/news-room/fact-sheets/detail/the-top-10-causes-of-death
  • Eisner MD, Blanc PD, Yelin EH, et al. Influence of anxiety on health outcomes in COPD. Thorax. 2010;65(3):229–234. doi: 10.1136/THX.2009.126201
  • Pooler A, Beech R. Examining the relationship between anxiety and depression and exacerbations of COPD which result in hospital admission: a systematic review. Int J COPD. 2014;9:315–330. doi: 10.2147/COPD.S53255
  • Hill K, Geist R, Goldstein RS, et al. Anxiety and depression in end-stage COPD. Eur Respir J. 2008 Mar;31(3):667–677.
  • Quynh Nguyen NT, Ngoc Huynh VA, To QG, et al. Factors associated with anxiety and depression among chronic obstructive pulmonary disease outpatients in Ho Chi Minh City, Vietnam. WHO South East Asia J Public Health. 2021 Jul 1;10(2):95–100. doi: 10.4103/WHO-SEAJPH.WHO_SEAJPH_149_21
  • Jose A, Chelangara D, S S. Factors associated with anxiety and depression in chronic obstructive pulmonary disease. Int J Res Med Sci. 2016;4(4):1074–1079. doi: 10.18203/2320-6012.IJRMS20160786
  • Turan GB, Tan M, Dayapoglu N. Investigation of the effects of illness perception on anxiety and depression in patients with COPD. Int J Caring Sci. 2019;12(2):699–708.
  • Xiao T, Qiu H, Chen Y, et al. Prevalence of anxiety and depression symptoms and their associated factors in mild COPD patients from community settings, Shanghai, China: a cross-sectional study. BMC Psychiatry. 2018;18(1):89. doi: 10.1186/s12888-018-1671-5
  • Liu D, Zou Y, Wang Y. Investigation on the relationship between sleep quality and depression and anxiety in hospitalized patients with different levels of AECOPD. Tang M, editor. Comput Math Methods Med. 2022 Apr 30;2022: 5901552. doi:10.1155/2022/5901552
  • Long J, Ouyang Y, Duan H, et al. Multiple factor analysis of depression and/or anxiety in patients with acute exacerbation chronic obstructive pulmonary disease. Int J COPD. 2020;15:1449–1464. doi: 10.2147/COPD.S245842
  • Janssen DJA, Spruit MA, Leue C, et al. Symptoms of anxiety and depression in COPD patients entering pulmonary rehabilitation. Chron Respir Dis. 2010 Aug;7(3):147–157. doi: 10.1177/1479972310369285
  • Household expenditures & income survey - department of statistics [Internet]. [cited 2024 Jan 11]. Available from: https://dosweb.dos.gov.jo/economic/expenditures-income/
  • 2024 GOLD Report - Global Initiative for Chronic Obstructive Lung Disease - GOLD [Internet]. 2024 [cited 2024 Jan 11]. Available from: https://goldcopd.org/2024-gold-report/
  • Al-Qerem W, Hammad AM, Gassar ES, et al. Spirometry reference equations for an adult middle eastern population. Expert Rev Respiratory Med. 2019 May 4;13(5):489–497. doi: 10.1080/17476348.2019.1601560
  • Jones PW, Harding G, Berry P, et al. Development and first validation of the COPD assessment test. Eur Respir J. 2009 Sep;34(3):648–654.
  • Al-Moamary MS, Al-Hajjaj MS, Tamim HM, et al. The reliability of an Arabic translation of the chronic obstructive pulmonary disease assessment test. Saudi Med J. 2011 Oct;32(10):1028–1033.
  • The Deutsche Atemwegsliga e.V. (German Airway League) Correct Inhalation Technique [Internet]. 2019 [cited 2022 Apr 28]. Available from: https://www.atemwegsliga.de/correct-inhalation.html
  • Zigmond AS, Snaith RP. The hospital anxiety and depression scale. Acta Psychiatr Scand. 1983 Jun 1;67(6):361–370. doi: 10.1111/J.1600-0447.1983.TB09716.X
  • Lichtenberg PA. Handbook of assessment in clinical gerontology. 2010. doi: 10.1016/C2009-0-01911-4
  • Terkawi A, Tsang S, Alkahtani G, et al. Development and validation of Arabic version of the hospital anxiety and depression scale. Saudi J Anaesth. 2017 May 1;11(Suppl 1):S11–8. doi: 10.4103/SJA.SJA_43_17
  • Felker B, Katon W, Hedrick SC, et al. The association between depressive symptoms and health status in patients with chronic pulmonary disease. Gen Hosp Psychiatry. 2001 Mar;23(2):56–61. doi: 10.1016/S0163-8343(01)00127-X
  • An J, Zhou H, Yang T, et al. Relationship of psychological factors with daily activities and quality of life in patients with chronic obstructive pulmonary disease in a Chinese rural population. Ann Palliat Med. 2021;10(2):1675–1684. doi: 10.21037/apm-20-1151
  • Husain MO, Chaudhry IB, Blakemore A, et al. Prevalence of depression and anxiety in patients with chronic obstructive pulmonary disease and their association with psychosocial outcomes: a cross-sectional study from Pakistan. SAGE Open Med. 2021;9:1–10. doi: 10.1177/20503121211032813
  • Cleland JA, Lee AJ, Hall S. Associations of depression and anxiety with gender, age, health-related quality of life and symptoms in primary care COPD patients. Fam Pract. 2007 Jun;24(3):217–223. doi: 10.1093/FAMPRA/CMM009
  • Tsai TY, Livneh H, Lu MC, et al. Increased risk and related factors of depression among patients with COPD: a population-based cohort study. BMC Public Health. 2013;13(1):976. doi: 10.1186/1471-2458-13-976
  • Hanania NA, Müllerova H, Locantore NW, et al. Determinants of depression in the ECLIPSE chronic obstructive pulmonary disease cohort. Am J Respir Crit Care Med. 2011 Mar 1;183(5):604–611. doi: 10.1164/RCCM.201003-0472OC
  • Kunik ME, Roundy K, Veazey C, et al. Surprisingly high prevalence of anxiety and depression in chronic breathing disorders. Chest. 2005;127(4):1205–1211. doi: 10.1016/S0012-3692(15)34468-8
  • Zhang Q, Liao J, Liao X, et al. Disease knowledge level is a noteworthy risk factor of anxiety and depression in patients with chronic obstructive pulmonary disease: a cross-sectional study. BMC Pulm Med. 2014 May 28;14(1):92. doi: 10.1186/1471-2466-14-92
  • Gudmundsson G, Gislason T, Janson C, et al. Depression, anxiety and health status after hospitalisation for COPD: a multicentre study in the Nordic countries. Respir Med. 2006 Jan;100(1):87–93.
  • Al-Qerem W, Hammad A, Amawi HA, et al. Anxiety and depression among pharmacy students before and during COVID-19 pandemic. Trop J Pharm Res. 2021 May 1;20(5):1039–1047. doi: 10.4314/TJPR.V20I5.22
  • Di Marco F, Verga M, Reggente M, et al. Anxiety and depression in COPD patients: the roles of gender and disease severity. Respir Med. 2006 Oct;100(10):1767–1774.
  • Quint JK, Baghai-Ravary R, Donaldson GC, et al. Relationship between depression and exacerbations in COPD. Eur Respir J.2008 Jul 1;32(1):53–60. doi: 10.1183/09031936.00120107
  • Jennings JH, Digiovine B, Obeid D, et al. The association between depressive symptoms and acute exacerbations of COPD. Lung. 2009 Apr;187(2):128–135. doi: 10.1007/S00408-009-9135-9
  • Laurin C, Lavoie KL, Bacon SL, et al. Sex differences in the prevalence of psychiatric disorders and psychological distress in patients with COPD. Chest. 2007;132(1):148–155. doi: 10.1378/CHEST.07-0134
  • Jenkins R, Bhugra D, Bebbington P, et al. Debt, income and mental disorder in the general population. Psychol Med. 2008 Oct;38(10):1485–1493.
  • Fryers T, Melzer D, Jenkins R. Social inequalities and the common mental disorders. Soc Psychiatry Psychiatr Epidemiol. 2003 May 1;38(5):229–237. doi: 10.1007/S00127-003-0627-2
  • Lorant V, Deliège D, Eaton W, et al. Socioeconomic inequalities in depression: a meta-analysis. Am J Epidemiol. 2003 Jan 15;157(2):98–112. doi: 10.1093/AJE/KWF182
  • Peen J, Schoevers RA, Beekman AT, et al. The current status of urban-rural differences in psychiatric disorders. Acta Psychiatr Scand. 2010 Feb 1;121(2):84–93. doi: 10.1111/J.1600-0447.2009.01438.X
  • How the city affects mental health - centre for Urban Design and mental health [internet]. UD/MH. [cited 2022 Nov 8]. Available from: https://www.urbandesignmentalhealth.com/how-the-city-affects-mental-health.html
  • Schneider C, Jick SS, Bothner U, et al. COPD and the risk of depression. Chest. 2010 Feb 1;137(2):341–347. doi: 10.1378/CHEST.09-0614
  • Yohannes AM, Müllerová H, Hanania NA, et al. Long-term course of depression trajectories in patients with COPD: a 3-year follow-up analysis of the evaluation of COPD longitudinally to identify predictive surrogate endpoints cohort. Chest. 2016 Apr 1;149(4):916–926. doi: 10.1016/J.CHEST.2015.10.081
  • Naka T, Ide S, Nakako T, et al. Activation of β-adrenoceptors in the bed nucleus of the stria terminalis induces food intake reduction and anxiety-like behaviors. Neuropharmacology. 2013 Apr;67:326–330. doi: 10.1016/J.NEUROPHARM.2012.11.021
  • Singh S, Loke YK, Enright P, et al. Pro-arrhythmic and pro-ischaemic effects of inhaled anticholinergic medications. Thorax. 2013;68(1):114–116. doi: 10.1136/THORAXJNL-2011-201275
  • Gupta P, O’Mahony MS. Potential adverse effects of bronchodilators in the treatment of airways obstruction in older people: recommendations for prescribing. Drugs Aging. 2008;25(5):415–443. doi: 10.2165/00002512-200825050-00005
  • Palapinyo S, Methaneethorn J, Leelakanok N. Association between polypharmacy and depression: a systematic review and meta-analysis. J Pharm Pract Res. 2021 Aug 1;51(4):280–299. doi: 10.1002/JPPR.1749
  • Cheng C, Bai J. Association Between Polypharmacy, anxiety, and depression among Chinese older adults: evidence from the Chinese Longitudinal Healthy Longevity Survey. CIA. 2022;17:235–244. doi: 10.2147/CIA.S351731
  • Bazargan M, Smith J, Saqib M, et al. Associations between polypharmacy, self-rated health, and depression in African American older adults; mediators and moderators. Int J Environ Res Public Health. 2019 May 1;16(9):1574. doi: 10.3390/IJERPH16091574
  • Volpato E, Toniolo S, Pagnini F, et al. The relationship between anxiety, depression and treatment adherence in chronic obstructive pulmonary disease: a systematic review. Int J Chron Obstruct Pulmon Dis. 2021 Jul;16:2001–2021. doi: 10.2147/COPD.S313841
  • Volpato E, Farver-Vestergaard I, Brighton LJ, et al. Nonpharmacological management of psychological distress in people with COPD. Eur Respir Rev. 2023 Mar 31;32(167):220170. doi: 10.1183/16000617.0170-2022
  • Poletti V, Pagnini F, Banfi P, et al. Illness perceptions, Cognitions, and beliefs on COPD Patients’ adherence to treatment – a systematic review. Patient Prefer Adherence. 2023 Jul;17:1845–1866. doi: 10.2147/PPA.S412136
  • Pozzar M, Volpato E, Valota C, et al. How people with chronic obstructive pulmonary disease perceive their illness: a qualitative study between mind and body. BMC Pulm Med. 2020 Dec 4;20(1):120. doi: 10.1186/s12890-020-1157-3
  • Bulut S, Karamanli H, Akın Kabalak P. Association of depression with improper use of inhaler devices by patients with obstructive disease. Clin Respir J. 2021 Jul 1;15(7):721–727. doi: 10.1111/CRJ.13353
  • Al-Kalaldeh M, Abd El-Rahman M, El-Ata A. Effectiveness of nurse-driven inhaler education on inhaler proficiency and compliance among obstructive lung disease patients: a quasi-experimental study. Can J Nurs Res. 2016 Jun 1;48(2):48–55. doi: 10.1177/0844562116676119
  • Koulouris N, Dimakou K, Gourgoulianis K, et al. Self-perceived quality of sleep among COPD patients in Greece: the SLEPICO study. Sci Rep. 2022 Jan 11;12(1):540. doi: 10.1038/s41598-021-04610-z

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.